Additional studies to clarify the specific inhibitors or promoters of these pathways, as well as transcription factors and post-transcription/translation modification methods, will help to identify the most appropriate therapeutic targets for AQP1 and AQP4 modulation, relationships between genes, and signaling pathways in gliomas. Here, AQP1 is linked to glioma.